2019
DOI: 10.1016/j.ejmech.2019.111683
|View full text |Cite
|
Sign up to set email alerts
|

Single-molecule chemiluminescent photosensitizer for a self-activating and tumor-selective photodynamic therapy of cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

8
67
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(75 citation statements)
references
References 49 publications
8
67
0
Order By: Relevance
“…Many other types of cancer have been the focus of PDT either as primary or complementary treatment, and the trend is similar in the majority of the new approaches. Gastric, colorectal, urogenital, bladder, and pancreatic cancer, besides previously discussed breast and lung cancers, are among the ones where PDT therapies have been deeply researched, either looking to improve the delivery of the known photosensitizers or oxygen, or improve the capability of the light source [ 155 , 156 , 157 , 158 , 159 , 160 , 161 ]. Nevertheless, the search for new photosensitizers is also an active target for the development of PDT.…”
Section: Photodynamic Therapymentioning
confidence: 99%
“…Many other types of cancer have been the focus of PDT either as primary or complementary treatment, and the trend is similar in the majority of the new approaches. Gastric, colorectal, urogenital, bladder, and pancreatic cancer, besides previously discussed breast and lung cancers, are among the ones where PDT therapies have been deeply researched, either looking to improve the delivery of the known photosensitizers or oxygen, or improve the capability of the light source [ 155 , 156 , 157 , 158 , 159 , 160 , 161 ]. Nevertheless, the search for new photosensitizers is also an active target for the development of PDT.…”
Section: Photodynamic Therapymentioning
confidence: 99%
“…C-TBD NPs could precisely monitor the tumor site via chemiluminescence imaging and efficiently inhibit tumor growth through PO-CL exciting TBD to produce in the presence of H 2 O 2 , thus realizing simultaneous tumor diagnosis and treatment. Coelenterazine and its analogs can also act as a self-activating agent for PDT (Pinto da Silva et al, 2019 ; Sun et al, 2019 ). In the presence of a superoxide anion (overexpressed in tumor cells), coelenterazine can be oxidized into a dioxetanone intermediate, which then decomposing into CO 2 and the excited coelenteramide.…”
Section: Chemiluminescence-mediated Photodynamic Therapymentioning
confidence: 99%
“…The product will further undergo intersystem crossing to the triplet state, thus inducing the generation of . This process can be enhanced by the introduction of a bromine heteroatom due to the heavy atom effect (Pinto da Silva et al, 2019 ).…”
Section: Chemiluminescence-mediated Photodynamic Therapymentioning
confidence: 99%
“…Singlet oxygen ( 1 O 2 ) [16,17] is the most effective ROS in destroying cancer cells and is widely used in PDT [18,19]. Singlet oxygen can be detected using fluorescent probes [20,21], the most selective one being the Singlet Oxygen Sensor Green (SOSG) [22].…”
Section: Introductionmentioning
confidence: 99%